Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2007-07-01 (18 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-ANDRE-LES-VERGERS (10120), Aube
PHARMACIE CHARLOTTE POUILLOT : revenue, balance sheet and financial ratios
PHARMACIE CHARLOTTE POUILLOT is a French company
founded 18 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-ANDRE-LES-VERGERS (10120),
this company of category PME
shows in 2022 a revenue of 2.9 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE CHARLOTTE POUILLOT (SIREN 498844158)
Indicator
2024
2023
2022
2021
2020
2019
2018
2016
Revenue
N/C
N/C
2 940 701 €
2 568 695 €
2 169 745 €
2 104 701 €
1 964 191 €
1 815 072 €
Net income
161 673 €
109 208 €
256 180 €
219 564 €
172 370 €
156 914 €
167 026 €
96 767 €
EBITDA
N/C
N/C
314 875 €
269 578 €
212 662 €
170 444 €
216 745 €
131 956 €
Net margin
N/C
N/C
8.7%
8.5%
7.9%
7.5%
8.5%
5.3%
Revenue and income statement
In 2024, PHARMACIE CHARLOTTE POUILLOT generates positive net income of 162 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 97 k€ -> 162 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
161 673 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 23%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
23.19%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
64.629%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE CHARLOTTE POUILLOT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2018
2019
2020
2021
2022
2023
2024
Debt ratio
50.27
38.43
36.28
32.837
23.536
15.86
35.412
23.19
Financial autonomy
54.241
60.926
62.076
62.761
64.326
69.935
71.256
64.629
Repayment capacity
4.132
2.184
2.667
2.056
1.421
0.859
None
None
Cash flow / Revenue
5.336%
8.894%
6.785%
8.26%
8.007%
8.379%
None%
None%
Sector positioning
Debt ratio
23.192024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good
In 2024, the debt ratio of PHARMACIE CHARLOTTE POUILLOT (23.19) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
64.63%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good-6 pts over 3 years
In 2024, the financial autonomy of PHARMACIE CHARLOTTE POUILLOT (64.6%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
0.86 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of PHARMACIE CHARLOTTE POUILLOT (0.86) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 135.05. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
135.053
Liquidity indicators evolution PHARMACIE CHARLOTTE POUILLOT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
70.539
140.308
161.929
168.414
163.499
171.371
852.265
135.053
Interest coverage
11.023
2.576
3.021
2.151
1.403
1.87
None
None
Sector positioning
Liquidity ratio
135.052024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average-9 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE CHARLOTTE POUILLOT (135.05) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
1.87x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Average
In 2022, the interest coverage of PHARMACIE CHARLOTTE POUILLOT (1.9x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE CHARLOTTE POUILLOT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2018
2019
2020
2021
2022
2023
2024
Operating WCR
104 457 €
176 168 €
216 490 €
255 639 €
242 151 €
48 992 €
0 €
0 €
Inventory turnover (days)
27
28
26
26
21
17
0
0
Customer payment term (days)
2
2
3
4
4
5
0
0
Supplier payment term (days)
52
50
51
50
53
0
0
0
Positioning of PHARMACIE CHARLOTTE POUILLOT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE CHARLOTTE POUILLOT is estimated at
2 257 074 €
(range 1 571 791€ - 3 376 712€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1571k€2257k€3376k€
2 257 074 €Range: 1 571 791€ - 3 376 712€
NAF 5 année 2024
Valuation method used
Net Income Multiple
161 673 €
×
14.0x
=2 257 075 €
Range: 1 571 791€ - 3 376 713€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE CHARLOTTE POUILLOT with other companies in the same sector:
Frequently asked questions about PHARMACIE CHARLOTTE POUILLOT
What is the revenue of PHARMACIE CHARLOTTE POUILLOT ?
The revenue of PHARMACIE CHARLOTTE POUILLOT in 2022 is 2.9 M€.
Is PHARMACIE CHARLOTTE POUILLOT profitable?
Yes, PHARMACIE CHARLOTTE POUILLOT generated a net profit of 162 k€ in 2024.
Where is the headquarters of PHARMACIE CHARLOTTE POUILLOT ?
The headquarters of PHARMACIE CHARLOTTE POUILLOT is located in SAINT-ANDRE-LES-VERGERS (10120), in the department Aube.
Where to find the tax return of PHARMACIE CHARLOTTE POUILLOT ?
The tax return of PHARMACIE CHARLOTTE POUILLOT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE CHARLOTTE POUILLOT operate?
PHARMACIE CHARLOTTE POUILLOT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart